ms MADELEINE BUGEL

H.R. 7024 Tax Relief for American Families and Workers Act of 2024 R & D Tax Credit

H.R. 7024: Tax Relief for American Families and Workers Act

H.R. 7024 Tax Relief for American Families and Workers Act of 2024 R & D Tax Credit

H.R. 7024: Tax Relief for American Families and Workers Act

S.J. Res 38: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Federal Highway Administration relating to "Waiver of Buy America Requirements for Electric Vehicle Chargers" Promoting Resilient Supply Chains Act Critical minerals issues.

S.J. Res 38: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Federal Highway Administration relating to "Waiver of Buy America Requirements for Electric Vehicle Chargers" Promoting Resilient Supply Chains Act Critical minerals issues.

S.J. Res 38: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Federal Highway Administration relating to "Waiver of Buy America Requirements for Electric Vehicle Chargers" Promoting Resilient Supply Chains Act Critical minerals issues.

Meeting with House staff on HR 471, the SHIP It Act. Meetings with House and Senate Staff on H.R. 471, Safer Highways and Increase Performance for Interstate Trucking Act, to promote increased fluidity of freight in the U.S. Meetings with Office of Management and Budget, Federal Highway Administration, and White House staff on implementation of the Infrastructure Investment and Jobs Act and the Build America, Buy America Act requirements for electrical equipment.

Meetings with House staff and members to support H.R. 471, Safer Highways and Increased Performance for Interstate Trucking Act.

Met with House staff on CRA resolution to overturn SEC rule on cyber incident disclosure Meeting with Senate and House staff on S.J. Res. 38 and the Build America, Buy America Act implementation to promote U.S. manufacturing. Meetings with House and Senate staff on distribution transformer energy efficiency legislation.

Advocacy on HR 4479/S2609, the Facilitating Innovative Nuclear Diagnostics (FIND) Act, to fix policy packaging for radiopharmaceuticals; Advocacy with CMS on Beta Amyloid PET Medicare Coverage; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and S. 4333, the CLEAR Act, to allow FDA to continue regulating all imaging agents as drugs. Advocacy with Congress and FDA on H.R. 7084/S.3983 PATCH Act to seek improvements related to cybersecurity requirements of installed base devices; Advocacy on H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act, to clarify the definition of remanufacturing and have education and enforcement of remanufacturers; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and provisions related to remanufacturing of medical devices and medical device cybersecurity; Advocacy on H.R. 2007 The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2021, to promote research and use of noninvasive treatment alternatives for uterine fibroids; Advocacy on Digital Millennium Copyright Act (DMCA) Section 1201 and Right to Repair issues broadly; Advocacy on focused ultrasound technology; advocacy on medical device cybersecurity.

Advocacy on HR 4479/S2609, the Facilitating Innovative Nuclear Diagnostics (FIND) Act, to fix policy packaging for radiopharmaceuticals; Advocacy with CMS on Beta Amyloid PET Medicare Coverage; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and S. 4333, the CLEAR Act, to allow FDA to continue regulating all imaging agents as drugs. Advocacy with Congress and FDA on H.R. 7084/S.3983 PATCH Act to seek improvements related to cybersecurity requirements of installed base devices; Advocacy on H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act, to clarify the definition of remanufacturing and have education and enforcement of remanufacturers; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and provisions related to remanufacturing of medical devices and medical device cybersecurity; Advocacy on H.R. 2007 The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2021, to promote research and use of noninvasive treatment alternatives for uterine fibroids; Advocacy on Digital Millennium Copyright Act (DMCA) Section 1201 and Right to Repair issues broadly; Advocacy on focused ultrasound technology; advocacy on medical device cybersecurity.

Advocacy on both S. 1260 United States Innovation and Competition Act of 2021 and H.R. 4521 America COMPETES Act of 2022 to support U.S. manufacturing competiveness in the global marketplace

Advocacy on both S. 1260 United States Innovation and Competition Act of 2021 and H.R. 4521 America COMPETES Act of 2022 to support U.S. manufacturing competiveness in the global marketplace

Advocacy on both S. 1260 United States Innovation and Competition Act of 2021 and H.R. 4521 America COMPETES Act of 2022 to support U.S. manufacturing competition in the global marketplace

Advocacy on Build America, Buy America Act guidance and requirements; Advocacy on S. 1260, the U.S. Innovation and Competition Act (USICA), to increase the competitiveness of U.S. businesses and manufacturing. Advocacy on HR 4521, the American COMPETES Act, to increase the competitiveness of U.S. businesses and manufacturing. Prepared and held meeting with the National acquisition center on numerous topics including: FORCE, Turnkey, and inspection process

Advocacy on S. 1260, the U.S. Innovation and Competition Act (USICA), to increase the competitiveness of U.S. businesses and manufacturing. Advocacy on HR 4521, the American COMPETES Act, to increase the competitiveness of U.S. businesses and manufacturing.

Advocacy on S. 1260, the U.S. Innovation and Competition Act (USICA), to increase the competitiveness of U.S. businesses and manufacturing. Advocacy on HR 4521, the American COMPETES Act, to increase the competitiveness of U.S. businesses and manufacturing.

Advocacy on S. 1260, the U.S. Innovation and Competition Act (USICA), to increase the competitiveness of U.S. businesses and manufacturing. Advocacy on HR 4521, the American COMPETES Act, to increase the competitiveness of U.S. businesses and manufacturing.

Advocacy on both S. 1260 United States Innovation and Competition Act of 2021 and H.R. 4521 America COMPETES Act of 2022 to support U.S. manufacturing competition in the global marketplace

Advocacy on S. 1260, the U.S. Innovation and Competition Act (USICA), to increase the competitiveness of U.S. businesses and manufacturing. Advocacy on HR 4521, the American COMPETES Act, to increase the competitiveness of U.S. businesses and manufacturing.

Advocacy on HR 4479/S2609, the Facilitating Innovative Nuclear Diagnostics (FIND) Act, to fix policy packaging for radiopharmaceuticals; Advocacy with CMS on Beta Amyloid PET Medicare Coverage; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and S. 4333, the CLEAR Act, to allow FDA to continue regulating all imaging agents as drugs. Advocacy with Congress and FDA on H.R. 7084/S.3983 PATCH Act to seek improvements related to cybersecurity requirements of installed base devices; Advocacy on H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act, to clarify the definition of remanufacturing and have education and enforcement of remanufacturers; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and provisions related to remanufacturing of medical devices and medical device cybersecurity; Advocacy on H.R. 2007 The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2021, to promote research and use of noninvasive treatment alternatives for uterine fibroids; Advocacy on Digital Millennium Copyright Act (DMCA) Section 1201 and Right to Repair issues broadly; Advocacy on focused ultrasound technology; advocacy on medical device cybersecurity.

Advocacy on HR 4479/S2609, the Facilitating Innovative Nuclear Diagnostics (FIND) Act, to fix policy packaging for radiopharmaceuticals; Advocacy with CMS on Beta Amyloid PET Medicare Coverage; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and S. 4333, the CLEAR Act, to allow FDA to continue regulating all imaging agents as drugs. Advocacy with Congress and FDA on H.R. 7084/S.3983 PATCH Act to seek improvements related to cybersecurity requirements of installed base devices; Advocacy on H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act, to clarify the definition of remanufacturing and have education and enforcement of remanufacturers; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and provisions related to remanufacturing of medical devices and medical device cybersecurity; Advocacy on H.R. 2007 The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2021, to promote research and use of noninvasive treatment alternatives for uterine fibroids; Advocacy on Digital Millennium Copyright Act (DMCA) Section 1201 and Right to Repair issues broadly; Advocacy on focused ultrasound technology; advocacy on medical device cybersecurity.

Advocacy on HR 4479/S2609, the Facilitating Innovative Nuclear Diagnostics (FIND) Act, to fix policy packaging for radiopharmaceuticals; Advocacy with CMS on Beta Amyloid PET Medicare Coverage; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and S. 4333, the CLEAR Act, to allow FDA to continue regulating all imaging agents as drugs. Advocacy with Congress and FDA on H.R. 7084/S.3983 PATCH Act to seek improvements related to cybersecurity requirements of installed base devices; Advocacy on H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act, to clarify the definition of remanufacturing and have education and enforcement of remanufacturers; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and provisions related to remanufacturing of medical devices and medical device cybersecurity; Advocacy on H.R. 2007 The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2021, to promote research and use of noninvasive treatment alternatives for uterine fibroids; Advocacy on Digital Millennium Copyright Act (DMCA) Section 1201 and Right to Repair issues broadly; Advocacy on focused ultrasound technology; advocacy on medical device cybersecurity.

Advocacy on S. 1260, the U.S. Innovation and Competition Act (USICA), to increase the competitiveness of U.S. businesses and manufacturing. Advocacy on HR 4521, the American COMPETES Act, to increase the competitiveness of U.S. businesses and manufacturing.

Advocacy on S. 1260, the U.S. Innovation and Competition Act (USICA), to increase the competitiveness of U.S. businesses and manufacturing. Advocacy on HR 4521, the American COMPETES Act, to increase the competitiveness of U.S. businesses and manufacturing.

Advocacy on both S. 1260 United States Innovation and Competition Act of 2021 and H.R. 4521 America COMPETES Act of 2022 to support U.S. manufacturing competition in the global marketplace

Met with USTR and DOC staff on barriers to trade and industry priorities for the Indo-Pacific Economic Framework and the US-EU Trade and Technology Council. Meetings with House and Senate staff on S. 1260, USICA regarding trade provisions including 301 exemptions, GSP and MTBs.

Advocacy on S. 1260, the U.S. Innovation and Competition Act (USICA), to increase the competitiveness of U.S. businesses and manufacturing. Advocacy on HR 4521, the American COMPETES Act, to increase the competitiveness of U.S. businesses and manufacturing.

Advocacy on both S. 1260 United States Innovation and Competition Act of 2021 and H.R. 4521 America COMPETES Act of 2022 to support U.S. manufacturing competition in the global marketplace

Advocacy on both S. 1260 United States Innovation and Competition Act of 2021 and H.R. 4521 America COMPETES Act of 2022 to support U.S. manufacturing competiveness in the global marketplace

Advocacy on both S. 1260 United States Innovation and Competition Act of 2021 and H.R. 4521 America COMPETES Act of 2022 to support U.S. manufacturing competiveness in the global marketplace

Advocacy on Build America, Buy America Act guidance and requirements; Advocacy on S. 1260, the U.S. Innovation and Competition Act (USICA), to increase the competitiveness of U.S. businesses and manufacturing. Advocacy on HR 4521, the American COMPETES Act, to increase the competitiveness of U.S. businesses and manufacturing. Prepared and held meeting with the National acquisition center on numerous topics including: FORCE, Turnkey, and inspection process

Advocacy on S. 1260, the U.S. Innovation and Competition Act (USICA), to increase the competitiveness of U.S. businesses and manufacturing. Advocacy on HR 4521, the American COMPETES Act, to increase the competitiveness of U.S. businesses and manufacturing.

Advocacy on HR 4479/S2609, the Facilitating Innovative Nuclear Diagnostics (FIND) Act, to fix policy packaging for radiopharmaceuticals; Advocacy with CMS on Beta Amyloid PET Medicare Coverage; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and S. 4333, the CLEAR Act, to allow FDA to continue regulating all imaging agents as drugs. Advocacy with Congress and FDA on H.R. 7084/S.3983 PATCH Act to seek improvements related to cybersecurity requirements of installed base devices; Advocacy on H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act, to clarify the definition of remanufacturing and have education and enforcement of remanufacturers; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and provisions related to remanufacturing of medical devices and medical device cybersecurity; Advocacy on H.R. 2007 The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2021, to promote research and use of noninvasive treatment alternatives for uterine fibroids; Advocacy on Digital Millennium Copyright Act (DMCA) Section 1201 and Right to Repair issues broadly; Advocacy on focused ultrasound technology; advocacy on medical device cybersecurity.

Advocacy on HR 4479/S2609, the Facilitating Innovative Nuclear Diagnostics (FIND) Act, to fix policy packaging for radiopharmaceuticals; Advocacy with CMS on Beta Amyloid PET Medicare Coverage; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and S. 4333, the CLEAR Act, to allow FDA to continue regulating all imaging agents as drugs. Advocacy with Congress and FDA on H.R. 7084/S.3983 PATCH Act to seek improvements related to cybersecurity requirements of installed base devices; Advocacy on H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act, to clarify the definition of remanufacturing and have education and enforcement of remanufacturers; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and provisions related to remanufacturing of medical devices and medical device cybersecurity; Advocacy on H.R. 2007 The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2021, to promote research and use of noninvasive treatment alternatives for uterine fibroids; Advocacy on Digital Millennium Copyright Act (DMCA) Section 1201 and Right to Repair issues broadly; Advocacy on focused ultrasound technology; advocacy on medical device cybersecurity.

Advocacy on HR 4479/S2609, the Facilitating Innovative Nuclear Diagnostics (FIND) Act, to fix policy packaging for radiopharmaceuticals; Advocacy with CMS on Beta Amyloid PET Medicare Coverage; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and S. 4333, the CLEAR Act, to allow FDA to continue regulating all imaging agents as drugs. Advocacy with Congress and FDA on H.R. 7084/S.3983 PATCH Act to seek improvements related to cybersecurity requirements of installed base devices; Advocacy on H.R. 7253, Clarifying Remanufacturing to Protect Patient Safety Act, to clarify the definition of remanufacturing and have education and enforcement of remanufacturers; Advocacy on HR 7667, the Food and Drug Administration Safety and Landmark Advancements Act of 2022 and provisions related to remanufacturing of medical devices and medical device cybersecurity; Advocacy on H.R. 2007 The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2021, to promote research and use of noninvasive treatment alternatives for uterine fibroids; Advocacy on Digital Millennium Copyright Act (DMCA) Section 1201 and Right to Repair issues broadly; Advocacy on focused ultrasound technology; advocacy on medical device cybersecurity.